Behandling af uraemisk osteodystrofi med laegemidler, som påvirker calcium-fosfor-omsaetningen

Translated title of the contribution: Treatment of mineral bone disorder with pharmaceuticals which influence the calcium phosphor turnover

Peter Vestergaard, Pia A Eiken

Abstract

This review discusses the mineral bone disorders in patients with chronic kidney disease. We focus on the management of these conditions by administration of calcium, vitamin D (ergocalciferol and cholecalciferol), vitamin D receptor activators (calcitriol, alphacalcidiol), phosphate binders and calcimimetics (cinacalcet).
Translated title of the contributionTreatment of mineral bone disorder with pharmaceuticals which influence the calcium phosphor turnover
Original languageDanish
JournalUgeskrift for Laeger
Volume174
Issue number47
Pages (from-to)2931-4
Number of pages4
ISSN0041-5782
Publication statusPublished - 2012

Fingerprint

Dive into the research topics of 'Treatment of mineral bone disorder with pharmaceuticals which influence the calcium phosphor turnover'. Together they form a unique fingerprint.

Cite this